new tirzepatide Breakthrough Obesity Drug FDA approves diabetes drug tirzepatide

And because obesity itself is a known driver of GI dysfunction, every data point carries an asterisk: Is this the drug or the disease its treating

However, it remains unlicensed by the MHRA and EMA for routine use in the UK, and access is currently limited to regulated research settings

Why Anxiety Can Get Worse This is one of the most common problems

Kim Boyd, M.D., chief medical officer at WeightWatchers

Pharmacies are only allowed to compound a medication if there is a legitimate medical need such as a drug shortage or a patient requiring a customized formulation

After a rough period that saw her consistently gaining weight, Dolores knew she needed a solution to her weight gain